Publicaciones en colaboración con investigadores/as de Hospital Universitario Virgen Macarena (31)

2024

  1. Efficacy and safety of a structured de-escalation from antipseudomonal β-lactams in bloodstream infections due to Enterobacterales (SIMPLIFY): an open-label, multicentre, randomised trial

    The Lancet Infectious Diseases, Vol. 24, Núm. 4, pp. 375-385

2023

  1. Direct-acting oral anticoagulants in antiphospholipid syndrome: A systematic review

    Medicina Clinica, Vol. 161, Núm. 2, pp. 65-77

2021

  1. Acute hepatitis C virus infection and direct-acting antiviral drugs: Perfect combination to eliminate the epidemic?

    International Journal of STD and AIDS, Vol. 32, Núm. 13, pp. 1257-1260

  2. Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials

    BMC Infectious Diseases, Vol. 21, Núm. 1

  3. Do specific antimicrobial stewardship interventions have an impact on carbapenem resistance in Gram-negative bacilli? A multicentre quasi-experimental ecological study: time-trend analysis and characterization of carbapenemases

    The Journal of antimicrobial chemotherapy, Vol. 76, Núm. 7, pp. 1928-1936

  4. Modifications of CD4 T cells, CD4/CD8 ratio and serum levels of soluble CD14 in HIV-HCV-coinfected patients after sustained HCV response induced by direct-acting antiviral agents: influence of liver cirrhosis

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 40, Núm. 9, pp. 1863-1871

2020

  1. Quasiexperimental intervention study protocol to optimise the use of new antibiotics in Spain: The NEW_SAFE project

    BMJ Open, Vol. 10, Núm. 7

2019

  1. Monocyte and Lymphocyte Activation and Regulation in Multiple Sclerosis Patients. Therapy Effects

    Journal of Neuroimmune Pharmacology, Vol. 14, Núm. 3, pp. 413-422

2018

  1. Diagnosis and empirical treatment for community-acquired pneumonia in special situations: immunocompromised HIV negative and elderly patients

    Medicine (Spain), Vol. 12, Núm. 53, pp. 3168-3173

  2. Diagnostic and therapeutic protocol for community-acquired pneumonia

    Medicine (Spain), Vol. 12, Núm. 53, pp. 3162-3167

  3. Diagnostic and therapeutic protocol for pleural infections

    Medicine (Spain), Vol. 12, Núm. 54, pp. 3231-3234

  4. Unsolicited consultation by infectious diseases specialist improves outcomes in patients with bloodstream infection: A prospective cohort study

    Journal of Infection, Vol. 77, Núm. 6, pp. 503-508

2017

  1. Impact of universal access to hepatitis C therapy on HIV-infected patients: implementation of the Spanish national hepatitis C strategy

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 36, Núm. 3, pp. 487-494

2016

  1. Sarcoidosis: an update on current pharmacotherapy options and future directions

    Expert Opinion on Pharmacotherapy, Vol. 17, Núm. 18, pp. 2431-2448

2015

  1. Efficacy of and risk of bleeding during pegylated interferon plus ribavirin treatment in HIV/HCV-coinfected patients with pretreatment thrombocytopenia

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 34, Núm. 9, pp. 1879-1884

2014

  1. Are hip hemiarthroplasty and total hip arthroplasty infections different entities? The importance of hip fractures

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 33, Núm. 8, pp. 1439-1448

  2. Predictors of early mortality in very elderly patients with bacteremia: A prospective multicenter cohort

    International Journal of Infectious Diseases, Vol. 26, pp. 83-87

2013

  1. Benefits from sustained virologic response to pegylated interferon plus ribavirin in HIV/hepatitis C virus-coinfected patients with compensated cirrhosis

    Clinical Infectious Diseases, Vol. 56, Núm. 11, pp. 1646-1653

  2. Reappraisal of the outcome of healthcare-associated and community-acquired bacteramia: A prospective cohort study

    BMC Infectious Diseases, Vol. 13, Núm. 1

2012

  1. Hepatitis C virus genotype 4 responds better to pegylated interferon with ribavirin than genotype 1 in HIV-infected patients

    AIDS, Vol. 26, Núm. 13, pp. 1721-1724